The Head and Neck Institute at the Mount Sinai Health System offers unparalleled expertise in the diagnosis and treatment of all diseases and tumors related to the head and neck and is recognized internationally for pioneering various minimally invasive techniques.
Department of Otolaryngology-Head and Neck Surgery Chairman Dr. Eric Genden was among the early adopters nationwide and the first in New York to treat oral and throat cancers with transoral robotic surgery (TORS). Today, the Head and Neck Institute houses the largest Robotic Surgery Program for Head and Neck Cancers in the country and treats more head and neck oncology patients than any other hospital or hospital system in New York. Clinical care is backed by various research studies; Division of Head and Neck Oncology Co-chief Dr. Brett Miles is spearheading the Sinai Robotic Surgery Trial (SIRS) and recently opened the MOUTH HPV research study at Mount Sinai in collaboration with Johns Hopkins University. One of the first of its kind, this study aims to provide the first data set delineating the HPV infection natural history and correlation of behavioral risk factors (i.e. smoking) on HPV-associated oral infections.
Our extraordinary head and neck oncology, rhinology, oral and maxillofacial surgery, reconstructive surgery, skull base surgery, sleep surgery and voice and swallowing specialists participate in research activities at the Head and Neck Cancer Research Program - the world's foremost resource for dormant cell research - and continue to develop new, less invasive surgical techniques. Our team works in a multidisciplinary approach with various experts at the Mount Sinai Health System, and provides comprehensive services, such as facial reconstruction, to maximize your outcome, function and quality of life.